Imunon (IMNN) CMO Douglas Faller Receives Stock Award

What Happened
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), was granted 3,626 shares on 2026-08-28 at an acquisition price of $1.60 per share, totaling about $5,802. The filing reports an "A" (award/grant) acquisition — this was compensation paid in stock, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-28; Price per share: $1.60; Total value: ~$5,802.
• Form 4 filing date: 2026-09-01 (appears to be filed within the SEC’s two-business-day deadline).
• Shares owned after transaction: Not reported in the Form 4 filing.
• Footnote: Stock granted in lieu of cash for a portion of base salary (Footnote F1).
• Transaction type: A = Award/Grant (compensation-related), not a purchase (P) or sale (S).

Context
Stock awards issued in lieu of cash salary are a common form of executive compensation and do not necessarily signal a personal bullish or bearish view. For retail investors, note this is compensation income converted into equity rather than an insider increasing or decreasing a stake via market trades.